Breast Cancer Newsfeed

… This study compares postdiagnosis breast cancer treatment outcomes between Medicare … appropriate and timely treatment in breast cancer impacts outcomes, factors affecting … . Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA …

… M, et al; acelERA Breast Cancer Study Investigators. Giredestrant for estrogen … HER2-negative, previously treated advanced breast cancer: results from the randomized, phase … Clinical Practice Guidelines in Oncology. Breast cancer, version 3.2025. Accessed …

… low or HER2-ultralow metastatic breast cancer, demonstrating the benefit of … treatment of patients with metastatic breast cancer,” Dave Fredrickson, executive vice … low or HER2-ultralow metastatic breast cancer following disease progression after one …

… .  "The absence of detectable breast cancer recurrences at the five-year … this surgery-free approach to breast cancer management," said principal investigator … in patients with early-stage breast cancer who respond favorably to chemotherapy …

… to their bodies following her breast cancer diagnosis. Abbie Paklos, 34, … likelihood of this being breast cancer was rare, but she … with stage 4 metastatic breast cancer in February. Doctors say … the realities of living with breast cancer.  “I’ve gotten …

… Thriving Beyond Breast Cancer, whose mission is to empower the breast cancer community through …

… members of a Secondary Breast Cancer Support Group have enjoyed … better too. Having secondary breast cancer can make you feel … groups like the Secondary Breast Cancer Support Group helps us … more about the Secondary Breast Cancer Support Group, call 01332 …

… with early-stage invasive breast cancer could safely avoid surgery … "The lack of breast cancer recurrence after five years … surgical approach to treating breast cancer." He attributed this … the treatment of invasive breast cancer could become a new …

… reduce your risk of HER2+ breast cancer recurrence. Talk to your doctor … take a stand against HER2+ breast cancer recurrence with NERLYNX. NERLYNX is … reduce your risk of HER2+ breast cancer. NERLYNX can cause side effects …

… terminal diagnosis after her breast cancer returned. 5 Trisha … was first diagnosed with breast cancer in 2008 following a … are the signs of breast cancer? BREAST cancer is the most common … get breast cancer. If it’s treated early enough, breast cancer can …

… a new diagnosis in her breast cancer battle. Katie, 34, … recently revealed that her breast cancer has progressed to stage … are the signs of breast cancer? BREAST cancer is the most common … get breast cancer. If it’s treated early enough, breast cancer can …

… or make proteins. In aggressive breast cancer, excess linoleic acid overstimulates mTORC1 … only in the triple-negative breast cancer cells. Further experiments showed linoleic … . One group had triple-negative breast cancer cells that naturally produced too …

… who, facing a terminal breast cancer diagnosis, decides to leave … to worry about something like breast cancer. I was 33.” But, … discovered turned out to be breast cancer — and it had spread … after receiving her Stage IV breast cancer diagnosis? Molly Kochan in …

… the time of her breast cancer diagnosis, molly died in … re-diagnosed with Stage IV breast cancer having already undergone chemotherapy, … a terminal diagnosis for breast cancer in 2015Part of exploring … ’t just grappling with breast cancer: she’s also dealing …

… for a type of breast cancer. The approval covers adult … -low or HER2-ultralow breast cancer who have received at … For Muscle-Invasive Bladder Cancer Patients The approval is … positive, HER2-low metastatic breast cancer with a median progression-free …

… after treatment. “Encouraging cancer survivors to be more … physical activity, sedentary behavior, cancer and death. They followed … had been diagnosed with breast cancer at least a year … data regarding the participants’ cancer stage. In addition, physical …

… harrowingly told that following her breast cancer diagnosis, Tammy wouldn' … had lost her father to cancer some years before and … treatments for those diagnosed with cancer and pushing for legislative … 'I was diagnosed with cancer aged 33 and my whole …

… brand name, Faslodex) in metastatic breast cancer, as well as its Phase …

… informative presentation on lung cancer screening, emphasizing its underutilization … cancer screening. Why Screen? “Lung cancer kills more women than breast and ovarian cancer … the American Cancer Society (2023), National Comprehensive Cancer Network (2022 …

… be used to detect cancer across different areas of … and genito-urinary tracts, breast, skin, brain, and others … significance of AI in transforming cancer diagnostics," adding: … identification of cases with cancer and flagging potential diagnostic …

… article (‘Ridiculous’ cuts to AI cancer tech funding in England could … in the diagnosis of skin cancer. The reality is different. Although … Catherine Sims points out that breast screening is no longer automatic … now have stage four bowel cancer; if I’d had my …

… her terminal stage four breast cancer diagnosis The former chat … of pounds for cervical cancer. Breast cancer is one of the … women are sometimes affected. Breast cancer can develop in men, … been treated. What causes breast cancer? A cancerous tumour starts …

… can increase the risk of cancer. Lichen sclerosis is a skin … white rash" on her breast. When it persisted, she sought … ,401 new cases of vulval cancer in 2017-2019 plus 761 … increases your risk of getting cancer on your vulva, penis or …

… HR-positive, HER2-low metastatic breast cancer, with a median progression-free … treatment for HR-positive metastatic breast cancer regardless of HER2 expression. Following … -low or HER2-ultralow metastatic breast cancer, demonstrating the benefit of treating …

… and HER2 ultralow chemotherapy-naïve breast cancer indication. Daiichi Sankyo discovered this … HR positive, HER2-low metastatic breast cancer. 866 subjects were enrolled … individuals with HER2 low metastatic breast cancer who have previously received systemic …